Andrew Hykes, President and CEO at Inari Medical, Inc. (NARI), sold 7,222 shares at $50.08 ($362K) on 2024-07-01, disclosed to the SEC on 2024-07-03.
Scheduled sale ($362k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.08 | 3,000 | $150K | 41.5% |
| 2 | $50.19 | 508 | $25K | 7.0% |
| 3 | $50.19 | 947 | $48K | 13.1% |
| 4 | $50.19 | 1,292 | $65K | 17.9% |
| 5 | $50.19 | 1,475 | $74K | 20.4% |
| Total | $50.14 avg | 7,222 |
| $362K |
| 100% |
| Filing → |
| NARI | SELL | 2024-10-31 | $150K | — | Filing → |
| NARI | SELL | 2024-08-22 | $150K | — | Filing → |
| NARI | SELL | 2024-07-24 | $166K | — | Filing → |